ClinicalTrials.Veeva

Menu

Pancreatic Cancer Recurrence in the Netherlands

U

UMC Utrecht

Status

Enrolling

Conditions

PDAC
Pancreas Cancer
Pancreatic Ductal Adenocarcinoma
Pancreatic Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT04605237
18-036/C

Details and patient eligibility

About

The aim of this nationwide, observational cohort study is to evaluate current surveillance strategies after primary resection of pancreatic ductal adenocarcinoma (PDAC) in the Netherlands, with regard to the detection, treatment and survival of PDAC recurrence.

Enrollment

1,750 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing a pancreatic resection (PPPD, Whipple, distal pancreatectomy or total pancreatectomy) for histologically proven PDAC in one of the 16 Dutch centers for pancreatic surgery

Exclusion criteria

  • Patients with 30-day postoperative mortality

Trial design

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Lois Daamen, MD; Iris van Goor, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems